Annual CFI
-$2.01 M
-$14.15 M-116.54%
31 December 2023
Summary:
GT Biopharma annual cash flow from investing activities is currently -$2.01 million, with the most recent change of -$14.15 million (-116.54%) on 31 December 2023. During the last 3 years, it has fallen by -$2.01 million (-100.00%). GTBP annual CFI is now -116.54% below its all-time high of $12.14 million, reached on 31 December 2022.GTBP Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$1000.00
-$7.86 M-100.01%
30 September 2024
Summary:
GT Biopharma quarterly cash flow from investing activities is currently -$1000.00, with the most recent change of -$7.86 million (-100.01%) on 30 September 2024. Over the past year, it has dropped by -$1.85 million (-100.05%). GTBP quarterly CFI is now -100.01% below its all-time high of $7.86 million, reached on 30 June 2024.GTBP Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$13.37 M
-$1.85 M-12.13%
30 September 2024
Summary:
GT Biopharma TTM cash flow from investing activities is currently $13.37 million, with the most recent change of -$1.85 million (-12.13%) on 30 September 2024. Over the past year, it has increased by +$8.35 million (+166.39%). GTBP TTM CFI is now -12.13% below its all-time high of $15.22 million, reached on 30 June 2024.GTBP TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTBP Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -116.5% | -100.0% | +166.4% |
| 3 y3 years | -100.0% | +100.0% | +151.4% |
| 5 y5 years | -5480.6% | -100.5% | +7858.3% |
GTBP Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -116.5% | +91.3% | -100.0% | +100.0% | -12.1% | +151.4% |
| 5 y | 5 years | -116.5% | +91.3% | -100.0% | +100.0% | -12.1% | +151.4% |
| alltime | all time | -116.5% | +91.3% | -100.0% | +100.0% | -12.1% | +151.4% |
GT Biopharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1000.00(-100.0%) | $13.37 M(-12.1%) |
| June 2024 | - | $7.86 M(+56.1%) | $15.22 M(+51.9%) |
| Mar 2024 | - | $5.03 M(+953.1%) | $10.01 M(-598.5%) |
| Dec 2023 | -$2.01 M(-116.5%) | $478.00 K(-74.1%) | -$2.01 M(-140.0%) |
| Sept 2023 | - | $1.84 M(-30.6%) | $5.02 M(+56.9%) |
| June 2023 | - | $2.66 M(-138.0%) | $3.20 M(+97.1%) |
| Mar 2023 | - | -$6.99 M(-193.1%) | $1.62 M(-86.6%) |
| Dec 2022 | $12.14 M(-152.7%) | $7.51 M(>+9900.0%) | $12.14 M(+59.2%) |
| Sept 2022 | - | $25.00 K(-97.7%) | $7.63 M(-141.4%) |
| June 2022 | - | $1.08 M(-69.4%) | -$18.43 M(-5.5%) |
| Mar 2022 | - | $3.53 M(+18.1%) | -$19.51 M(-15.3%) |
| Dec 2021 | -$23.04 M(<-9900.0%) | $2.99 M(-111.5%) | -$23.04 M(-11.5%) |
| Sept 2021 | - | -$26.03 M(<-9900.0%) | -$26.03 M(<-9900.0%) |
| June 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2020 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2019 | $200.00 K(-655.6%) | $0.00(-100.0%) | $200.00 K(+19.0%) |
| Sept 2019 | - | $200.00 K(>+9900.0%) | $168.00 K(-594.1%) |
| June 2019 | - | $0.00(-100.0%) | -$34.00 K(-5.6%) |
| Dec 2018 | -$36.00 K(+800.0%) | -$32.00 K(+1500.0%) | -$36.00 K(+350.0%) |
| Sept 2018 | - | -$2000.00(<-9900.0%) | -$8000.00(+33.3%) |
| June 2018 | - | $0.00(-100.0%) | -$6000.00(0.0%) |
| Mar 2018 | - | -$2000.00(-50.0%) | -$6000.00(+50.0%) |
| Dec 2017 | -$4000.00(<-9900.0%) | -$4000.00(<-9900.0%) | -$4000.00(<-9900.0%) |
| Sept 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2017 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2016 | $0.00(-100.0%) | - | - |
| Dec 2015 | -$1000.00(-83.3%) | - | - |
| Dec 2014 | -$6000.00(<-9900.0%) | -$6000.00(<-9900.0%) | -$6000.00(<-9900.0%) |
| Sept 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2013 | - | $0.00(0.0%) | -$2000.00(0.0%) |
| June 2013 | - | $0.00(0.0%) | -$2000.00(0.0%) |
| Mar 2013 | - | $0.00(-100.0%) | -$2000.00(0.0%) |
| Dec 2012 | -$2000.00(<-9900.0%) | -$2000.00(<-9900.0%) | -$2000.00(<-9900.0%) |
| Sept 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2010 | $0.00(-100.0%) | - | - |
| Dec 2007 | $2.76 M(-2657.4%) | -$72.00 K(-50.0%) | $2.76 M(-2.5%) |
| Sept 2007 | - | -$144.00 K(+77.8%) | $2.83 M(-3.7%) |
| June 2007 | - | -$81.00 K(-102.6%) | $2.94 M(-0.7%) |
| Mar 2007 | - | $3.06 M(<-9900.0%) | $2.96 M(-2841.7%) |
| Dec 2006 | -$108.00 K(-98.2%) | -$2000.00(-94.4%) | -$108.00 K(-98.2%) |
| Sept 2006 | - | -$36.00 K(-40.0%) | -$5.99 M(-0.3%) |
| June 2006 | - | -$60.00 K(+500.0%) | -$6.01 M(-0.2%) |
| Mar 2006 | - | -$10.00 K(-99.8%) | -$6.02 M(-0.9%) |
| Dec 2005 | -$6.07 M | -$5.88 M(>+9900.0%) | -$6.07 M(+2451.7%) |
| Sept 2005 | - | -$56.00 K(-25.3%) | -$238.00 K(-15.0%) |
| June 2005 | - | -$75.00 K(+21.0%) | -$280.00 K(-1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2005 | - | -$62.00 K(+37.8%) | -$284.00 K(-8.1%) |
| Dec 2004 | -$309.00 K(+215.3%) | -$45.00 K(-54.1%) | -$309.00 K(+12.4%) |
| Sept 2004 | - | -$98.00 K(+24.1%) | -$275.00 K(+48.6%) |
| June 2004 | - | -$79.00 K(-9.2%) | -$185.00 K(-14.7%) |
| Mar 2004 | - | -$87.00 K(+690.9%) | -$217.00 K(+121.4%) |
| Dec 2003 | -$98.00 K(-45.6%) | -$11.00 K(+37.5%) | -$98.00 K(-36.4%) |
| Sept 2003 | - | -$8000.00(-92.8%) | -$154.00 K(-3.8%) |
| June 2003 | - | -$111.00 K(-446.9%) | -$160.00 K(+34.5%) |
| Mar 2003 | - | $32.00 K(-147.8%) | -$119.00 K(-33.9%) |
| Dec 2002 | -$180.00 K(+15.4%) | -$67.00 K(+378.6%) | -$180.00 K(-11.8%) |
| Sept 2002 | - | -$14.00 K(-80.0%) | -$204.00 K(+8.5%) |
| June 2002 | - | -$70.00 K(+141.4%) | -$188.00 K(+5.0%) |
| Mar 2002 | - | -$29.00 K(-68.1%) | -$179.00 K(+14.7%) |
| Dec 2001 | -$156.00 K(-48.5%) | -$91.00 K(-4650.0%) | -$156.00 K(-4.3%) |
| Sept 2001 | - | $2000.00(-103.3%) | -$163.00 K(-36.1%) |
| June 2001 | - | -$61.00 K(+916.7%) | -$255.00 K(+8.5%) |
| Mar 2001 | - | -$6000.00(-93.9%) | -$235.00 K(-22.4%) |
| Dec 2000 | -$303.00 K(-114.1%) | -$98.00 K(+8.9%) | -$303.00 K(-223.7%) |
| Sept 2000 | - | -$90.00 K(+119.5%) | $245.00 K(+4.3%) |
| June 2000 | - | -$41.00 K(-44.6%) | $235.00 K(+33.5%) |
| Mar 2000 | - | -$74.00 K(-116.4%) | $176.00 K(-91.8%) |
| Dec 1999 | $2.15 M(-1175.0%) | $450.00 K(-550.0%) | $2.15 M(+26.5%) |
| Sept 1999 | - | -$100.00 K(0.0%) | $1.70 M(0.0%) |
| June 1999 | - | -$100.00 K(-105.3%) | $1.70 M(-5.6%) |
| Mar 1999 | - | $1.90 M(>+9900.0%) | $1.80 M(-1000.0%) |
| Dec 1998 | -$200.00 K(+100.0%) | $0.00(-100.0%) | -$200.00 K(0.0%) |
| Sept 1998 | - | -$100.00 K(<-9900.0%) | -$200.00 K(0.0%) |
| June 1998 | - | $0.00(-100.0%) | -$200.00 K(+100.0%) |
| Mar 1998 | - | -$100.00 K(<-9900.0%) | -$100.00 K(0.0%) |
| Dec 1997 | -$100.00 K(-75.0%) | $0.00(-100.0%) | -$100.00 K(-80.0%) |
| Sept 1997 | - | -$100.00 K(-200.0%) | -$500.00 K(+25.0%) |
| June 1997 | - | $100.00 K(-200.0%) | -$400.00 K(0.0%) |
| Mar 1997 | - | -$100.00 K(-75.0%) | -$400.00 K(0.0%) |
| Dec 1996 | -$400.00 K(-200.0%) | -$400.00 K(<-9900.0%) | -$400.00 K(-180.0%) |
| Sept 1996 | - | $0.00(-100.0%) | $500.00 K(+400.0%) |
| June 1996 | - | $100.00 K(-200.0%) | $100.00 K(-50.0%) |
| Mar 1996 | - | -$100.00 K(-120.0%) | $200.00 K(-50.0%) |
| Dec 1995 | $400.00 K(-300.0%) | $500.00 K(-225.0%) | $400.00 K(+33.3%) |
| Sept 1995 | - | -$400.00 K(-300.0%) | $300.00 K(+200.0%) |
| June 1995 | - | $200.00 K(+100.0%) | $100.00 K(-200.0%) |
| Mar 1995 | - | $100.00 K(-75.0%) | -$100.00 K(-50.0%) |
| Dec 1994 | -$200.00 K(-110.0%) | $400.00 K(-166.7%) | -$200.00 K(-66.7%) |
| Sept 1994 | - | -$600.00 K(<-9900.0%) | -$600.00 K(-185.7%) |
| June 1994 | - | $0.00(0.0%) | $700.00 K(-66.7%) |
| Mar 1994 | - | $0.00(0.0%) | $2.10 M(+5.0%) |
| Dec 1993 | $2.00 M(+300.0%) | $0.00(-100.0%) | $2.00 M(-23.1%) |
| Sept 1993 | - | $700.00 K(-50.0%) | $2.60 M(+62.5%) |
| June 1993 | - | $1.40 M(-1500.0%) | $1.60 M(+220.0%) |
| Mar 1993 | - | -$100.00 K(-116.7%) | $500.00 K(0.0%) |
| Dec 1992 | $500.00 K(-600.0%) | $600.00 K(-300.0%) | $500.00 K(-600.0%) |
| Sept 1992 | - | -$300.00 K(-200.0%) | -$100.00 K(-150.0%) |
| June 1992 | - | $300.00 K(-400.0%) | $200.00 K(-300.0%) |
| Mar 1992 | - | -$100.00 K | -$100.00 K |
| Dec 1991 | -$100.00 K | - | - |
FAQ
- What is GT Biopharma annual cash flow from investing activities?
- What is the all time high annual CFI for GT Biopharma?
- What is GT Biopharma annual CFI year-on-year change?
- What is GT Biopharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for GT Biopharma?
- What is GT Biopharma quarterly CFI year-on-year change?
- What is GT Biopharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for GT Biopharma?
- What is GT Biopharma TTM CFI year-on-year change?
What is GT Biopharma annual cash flow from investing activities?
The current annual CFI of GTBP is -$2.01 M
What is the all time high annual CFI for GT Biopharma?
GT Biopharma all-time high annual cash flow from investing activities is $12.14 M
What is GT Biopharma annual CFI year-on-year change?
Over the past year, GTBP annual cash flow from investing activities has changed by -$14.15 M (-116.54%)
What is GT Biopharma quarterly cash flow from investing activities?
The current quarterly CFI of GTBP is -$1000.00
What is the all time high quarterly CFI for GT Biopharma?
GT Biopharma all-time high quarterly cash flow from investing activities is $7.86 M
What is GT Biopharma quarterly CFI year-on-year change?
Over the past year, GTBP quarterly cash flow from investing activities has changed by -$1.85 M (-100.05%)
What is GT Biopharma TTM cash flow from investing activities?
The current TTM CFI of GTBP is $13.37 M
What is the all time high TTM CFI for GT Biopharma?
GT Biopharma all-time high TTM cash flow from investing activities is $15.22 M
What is GT Biopharma TTM CFI year-on-year change?
Over the past year, GTBP TTM cash flow from investing activities has changed by +$8.35 M (+166.39%)